Methylphenidate Capsules for Morning ADHD Symptom Control Methylphenidate Capsules for Morning ADHD Symptom Control
Newly approved delayed- and extended-release methylphenidate capsules designed for bedtime administration may provide better early morning symptom control for ADHD patients.Pediatric Pharmacotherapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2019 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Amid America's opioid crisis, deaths from stimulants are steadily rising
Overdose deaths involving cocaine and psychotstimulants such as methamphematines, MDMA, methylphenidate (commonly sold as Ritalin) and caffeine have been steadily rising, according to a new report from the US Centers for Disease Control and Prevention. (Source: CNN.com - Health)
Source: CNN.com - Health - May 2, 2019 Category: Consumer Health News Source Type: news

Lannett To Launch Generic Concerta(R), AB-rated Methylphenidate Hydrochloride ER Tablets
PHILADELPHIA, April 30, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it expects to launch later this quarter Methylphenidate Hydrochloride Extended Release (ER) tablets USP (CII) in 18 mg, 27 mg,... Biopharmaceuticals, Generics, Product Launch Lannett, Concerta , Methylphenidate (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 30, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves First Medical Device To Treat ADHD In Children
(CNN) — The first medical device to treat childhood attention deficit hyperactivity disorder, or ADHD, was OK’d Friday by the US Food and Drug Administration. Designated for children ages 7 to 12 who are not currently on medication for the disorder, the device delivers a low-level electrical pulse to the parts of the brain responsible for ADHD symptoms. “This new device offers a safe, non-drug option for treatment of ADHD in pediatric patients through the use of mild nerve stimulation, a first of its kind,” Carlos Peña, director of the Division of Neurological and Physical Medicine Devices in...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 22, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN ADHD Source Type: news

Medical News Today: Concerta vs. Adderall: What's the difference?
Concerta and Adderall are both medications that can help treat the symptoms of attention deficit hyperactivity disorder (ADHD). Learn about the differences between them and the possible side effects in this article. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 10, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news

Medical News Today: Ritalin vs. Adderall: What's the difference?
Ritalin and Adderall are different types of stimulant medication that doctors can prescribe to help treat ADHD. Learn about the differences between them and the possible side effects here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 10, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news

Might microdosing psychedelics be safe and beneficial? An initial exploration - Fadiman J, Korb S.
Albert Hoffman suggested that low doses of LSD might be an appropriate alternative to Ritalin. Following this possibility, a systematic exploration of the effects of "microdoses," comprising hundreds of lengthy descriptive reports, was undertaken. Based on... (Source: SafetyLit)
Source: SafetyLit - April 4, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Can delayed/extended-release methylphenidate allow for once daily evening dosing in ADHD?
(Mary Ann Liebert, Inc./Genetic Engineering News) A new three-part study showed that a delayed-release, extended-release form of methylphenidate could be given to adults in the evening with or without food and would not exert any clinically meaningful effect for at least 10 hours after administration. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 2, 2019 Category: International Medicine & Public Health Source Type: news

ANI Pharmaceuticals Announces Two Generic Product Launches
BAUDETTE, Minn., March 27, 2019 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced the launch of 18mg and 27mg Methylphenidate Hydrochloride Extended-Release T... Biopharmaceuticals, Generics, Product Launch ANI Pharmaceuticals, Methylphenidate, Attention Deficit Hyperactivity Disorder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 27, 2019 Category: Pharmaceuticals Source Type: news

Childhood methylphenidate treatment predicts antidepressant use during adolescence
(Bar-Ilan University) A new, 12-year longitudinal study, which monitored 6,830 children from early childhood into adolescence, has shown that consistent treatment with MPH-based medications during childhood increases the risk of antidepressant use during adolescence. The study is the first of its kind to examine the connection between children diagnosed with ADHD and prescribed MPH between the ages of six and eight, and future dispensed prescriptions of antidepressants. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 27, 2019 Category: International Medicine & Public Health Source Type: news

Psychosis Risk Varies With ADHD Meds, Still Small
In the study, people who took amphetamines, like Adderall and Vyvanse, seemed to carry a relatively greater risk than the methylphenidates Ritalin and Concerta. (Source: WebMD Health)
Source: WebMD Health - March 21, 2019 Category: Consumer Health News Source Type: news

In Youth With ADHD, New-Onset Psychosis Up With Amphetamines
THURSDAY, March 21, 2019 -- For adolescents and young adults with attention-deficit/hyperactivity disorder (ADHD), new-onset psychosis occurs more often with amphetamine use versus methylphenidate use, according to a study published in the March 21... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Young people on amphetamines for ADHD have twice the psychosis risk compared to other stimulants, study says
Teens and young adults with attention deficit-hyperactivity disorder, ADHD, who receive amphetamines such as Adderall for treatment have a higher risk of developing psychosis, compared to those who receive methyphenidates stimulants, such as Ritalin, according to a large new study. (Source: CNN.com - Health)
Source: CNN.com - Health - March 20, 2019 Category: Consumer Health News Source Type: news

Some ADHD Meds Tied to a Higher Psychosis Risk Than Others Some ADHD Meds Tied to a Higher Psychosis Risk Than Others
Amphetamines are associated with a higher psychosis risk than methylphenidate in young patients who take these agents to treat attention deficit hyperactivity disorder.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - March 20, 2019 Category: Primary Care Tags: Psychiatry News Source Type: news

With ADHD, amphetamine has double the psychosis risk of methylphenidate
(Reuters Health) - Children and young adults with attention deficit-hyperactivity disorder (ADHD) who are treated with the stimulants amphetamine or methylphenidate face a small but significant risk of developing psychosis, with amphetamine products twice as likely to spark at problem, researchers say. (Source: Reuters: Health)
Source: Reuters: Health - March 20, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Popular Spice Rivals Stimulant for ADHD Popular Spice Rivals Stimulant for ADHD
The popular and expensive spice saffron appears to be as effective as the stimulant methylphenidate in treating symptoms in youngsters with ADHD, new research suggests.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - March 11, 2019 Category: Psychiatry Tags: Psychiatry News Source Type: news

Adhansia XR (Methylphenidate Hydrochloride Extended-release Capsules) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 7, 2019 Category: Drugs & Pharmacology Source Type: news

FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the Treatment of ADHD
STAMFORD, Conn.--(BUSINESS WIRE) March 01, 2019 --Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., announced that the U.S. Food and Drug Administration (FDA) approved Adhansia XR (methylphenidate hydrochloride) extended-release capsules... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 1, 2019 Category: Drugs & Pharmacology Source Type: news

Nootropics, or ‘Smart Drugs,’ Are Gaining Popularity. But Should You Take Them?
The idea that a pill can supersize human intelligence is decidedly science fiction. But plenty of real-world researchers and drug-makers are working to develop nootropics: pills, supplements and other substances designed to improve various aspects of cognition. A rough translation for the word “nootropic” comes from the Greek for “to bend or shape the mind.” And already, there are dozens of over-the-counter (OTC) products—many of which are sold widely online or in stores—that claim to boost creativity, memory, decision-making or other high-level brain functions. Some of the most popular ...
Source: TIME: Health - January 23, 2019 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Drugs Source Type: news

Animal Study Suggests Ritalin Won't Harm the Heart
Title: Animal Study Suggests Ritalin Won't Harm the HeartCategory: Health NewsCreated: 1/9/2019 12:00:00 AMLast Editorial Review: 1/10/2019 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - January 10, 2019 Category: Pediatrics Source Type: news

Animal Study Suggests Ritalin Won't Harm the Heart
WEDNESDAY, Jan. 9, 2019 -- Ritalin, a widely used stimulant drug to treat attention-deficit/hyperactivity disorder (ADHD), likely poses no risk of heart damage in children, new research in monkeys suggests. The findings are " very reassuring, " said... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 9, 2019 Category: General Medicine Source Type: news

Ritalin drives greater connection between brain areas key to memory, attention
(University of Wisconsin-Madison) Louis Populin and collaborators at the University of Wisconsin-Madison collaborators published a study this week in the Journal of Neuroscience describing increased connections between key parts of the brains of monkeys who have taken methylphenidate (Ritalin). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 12, 2018 Category: International Medicine & Public Health Source Type: news

Possible Tie to First-Line ADHD Drug and Psychotic Symptoms Possible Tie to First-Line ADHD Drug and Psychotic Symptoms
Noting the quality of the data may be questionable, researchers are warning clinicians about the possibility that methylphenidate may carry a risk for hallucinations and other psychotic symptoms in kids.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 30, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

One of the most popular ADHD drugs may cause hallucinations and other psychotic symptoms
(Exeley Inc.) One of the most popular ADHD drugs may cause hallucinations and other psychotic symptoms. Research published in the SJCAPP says that possible adverse symptoms may affect 1.1 percent -- 2.5 percent of ADHD patients treated with methylphenidate. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 22, 2018 Category: International Medicine & Public Health Source Type: news

Jornay PM (Methylphenidate Hydrochloride Extended-release Capsules ) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 17, 2018 Category: Drugs & Pharmacology Source Type: news

Methylphenidate Good First - Choice Pediatric ADHD Drug
For adults, amphetamines are reasonable first choice to treat attention - deficit hyperactivity disorder (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - August 17, 2018 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Neurology, Nursing, Pediatrics, Pharmacy, Psychiatry, Journal, Source Type: news

Methylphenidate Good First-Choice Pediatric ADHD Drug
THURSDAY, Aug. 16, 2018 -- Methylphenidate should be considered as a first choice for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents, while amphetamines should be considered as a first choice in adults,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 16, 2018 Category: Pharmaceuticals Source Type: news

FDA Clears First ADHD Bedtime Medication FDA Clears First ADHD Bedtime Medication
Jornay PM is a novel formulation of methylphenidate taken in the evening instead of first thing in the morning to provide early-morning control of attention-deficit/hyperactivity disorder (ADHD) symptoms.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Methylphenidate Best First-Line Drug Choice for ADHD in Kids Methylphenidate Best First-Line Drug Choice for ADHD in Kids
Methylphenidate appears to be the best first-line drug choice for attention- deficit/hyperactivity disorder (ADHD) in children and adolescents, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

FDA Approves Jornay PM (methylphenidate) Extended-Release Capsules for Attention Deficit Hyperactivity Disorder (ADHD)
GEORGE TOWN, Cayman Islands--(BUSINESS WIRE)August 09, 2018 --Ironshore Pharmaceuticals& Development, Inc. ( “Ironshore”) a wholly owned subsidiary of Highland Therapeutics Inc. (“Highland”) announced today that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 10, 2018 Category: Drugs & Pharmacology Source Type: news

Which Drugs Work Best for ADHD? Large Study Zeroes in on Two
The researchers compared seven ADHD drugs -- amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate and modafinil -- and a placebo over 12 weeks of treatment. (Source: WebMD Health)
Source: WebMD Health - August 8, 2018 Category: Consumer Health News Source Type: news

ADHD experts say more children with condition should be given drugs
An NHS-funded study has found that Ritalin is still the best medical option for children with ADHD – reducing symptoms by 78 per cent. Only 0.5 per cent of under-16s in the UK receive the drugs currently. (Source: the Mail online | Health)
Source: the Mail online | Health - August 8, 2018 Category: Consumer Health News Source Type: news

Which Drugs Work Best for ADHD? Large Study Zeroes in on Two
WEDNESDAY, Aug. 8, 2018 -- Researchers have identified what they describe as the safest, most effective short-term drug treatments for attention deficit/hyperactivity disorder (ADHD). It's methylphenidate for kids and amphetamines for adults,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 8, 2018 Category: General Medicine Source Type: news

Ritalin-type drugs best to treat ADHD in children, shows study
Methylphenidate drugs safest and most effective while adults do better on amphetaminesRitalin and other drugs of the same class are the most effective and safest medications to prescribe for children with attention deficit hyperactivity disorder (ADHD), according to a major scientific review.The review of ADHD drugs shows that they work, and work well, in spite of concerns among the public and some doctors that children in the UK are being overmedicated. Ofsted ’s chief inspector, Amanda Spielman, has likened the drugs to a “chemical cosh” and claimed they were being overprescribed, disguising bad behavio...
Source: Guardian Unlimited Science - August 8, 2018 Category: Science Authors: Sarah Boseley Health editor Tags: Attention deficit hyperactivity disorder Mental health UK news Source Type: news

ADHD experts say more children with condition should be given drugs as only one in ten currently are
An NHS-funded study has found that Ritalin is still the best medical option for children with ADHD – reducing symptoms by 78 per cent. Only 0.5 per cent of under-16s in the UK receive the drugs currently. (Source: the Mail online | Health)
Source: the Mail online | Health - August 8, 2018 Category: Consumer Health News Source Type: news

Methylphenidate best drug for hyperactive kids in short-term
But consider non-drug options first, concludes pooled analysis of data from 133 trials Related items fromOnMedica Monthly testing with isotretinoin might be unnecessary CBT helps children to kick obsessions Lorazepam no better than diazepam for child seizures Broader definition of ADHD raises risk of needless treatment One in 10 children in phase I cancer trials respond to drugs (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 8, 2018 Category: UK Health Source Type: news

Meds not the only answer for ADHD | Letters
There need to be national multi-agency collaborative pathways for the holistic assessment of children with attention difficultiesWe, as chartered psychologists (BPS), are delighted that the inadequate provision for children with mental health difficulties in the UK was highlighted (Shocking failures on children with ADHD, 4 August). We agree with the findings that there are considerable local differences in practice in this field. We note with concern the reported rise in prescriptions for stimulant drugs such as Ritalin (methylphenidate) between 2010 and 2015. We should not fall into the trap of believing that diagnosis a...
Source: Guardian Unlimited Science - August 6, 2018 Category: Science Authors: Letters Tags: Attention deficit hyperactivity disorder Society Health Mental health NHS Conservatives Politics Psychology Science Source Type: news

UB research suggests how stimulant treatments for ADHD work
(University at Buffalo) Stimulant medications are an effective treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). In the classroom, parents and teachers say that medications like methylphenidate (MPH) can reduce symptoms and improve behavior.Although stimulants have been in use for decades to treat ADHD in school-aged children, just how they work hasn't been clear. But the results of a new study in The Journal of Child Psychology and Psychiatry is filling in critical gaps about the role of improved cognitive functions. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 27, 2018 Category: International Medicine & Public Health Source Type: news

ADHD Medications Unlikely To Improve School Performance In Kids Without ADHD
BOSTON (CBS) — Many college students who don’t have ADHD illegally use ADHD medications, like Adderall and Ritalin, to try to boost their performance in school. But is that a smart way to go? Probably not, according to a new study from the University of Rhode Island and Brown University. Researchers looked at 13 undergrads and found that Adderall did improve attention and focus but that did not result in better performance of tests. The drug also appeared to impair working memory. This was a very small study so more research is needed, but in the meantime, students who don’t have ADHD should be discourage...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 23, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated Local Uncategorized ADHD Dr. Mallika Marshall Local TV Source Type: news

Use of Ritalin and other 'smart drugs' doubled in last decade in UK
Head of Ofsted Amanda Spielman said the figures were worrying and warned parents against using quick fix drugs. There were 1.5 million prescriptions in the last year in Britain by the NHS. (Source: the Mail online | Health)
Source: the Mail online | Health - June 26, 2018 Category: Consumer Health News Source Type: news

Use of Ritalin and other 'smart drugs' has DOUBLED in last decade in Britain
Head of Ofsted Amanda Spielman said the figures were worrying and warned parents against using quick fix drugs. There were 1.5 million prescriptions in the last year in Britain by the NHS. (Source: the Mail online | Health)
Source: the Mail online | Health - June 26, 2018 Category: Consumer Health News Source Type: news

Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 22, 2018 Category: Drugs & Pharmacology Source Type: news

NRA's incoming president ties Ritalin to school shootings
Oliver North, the National Rifle Association's incoming president, suggested on "Fox News Sunday" that Ritalin -- a drug commonly used to treat ADHD -- is somehow linked with school shootings. Experts weigh in on that idea. (Source: CNN.com - Health)
Source: CNN.com - Health - May 22, 2018 Category: Consumer Health News Source Type: news

Ritalin does NOT turn kids into killers, doctors say after the NRA blamed ADHD drugs for shootings   
Doctors are hitting back to refute claims from incoming NRA president Lt Col Oliver North's claims that ADHD medications like Ritalin could drive students to violence like Friday's school shooting. (Source: the Mail online | Health)
Source: the Mail online | Health - May 21, 2018 Category: Consumer Health News Source Type: news

NRA links school violence to Ritalin but experts deny connection
If anything, experts say, children on the medication tend to be less aggressive (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 21, 2018 Category: Consumer Health News Source Type: news

Huge surge in kids poisoned by ADHD pills since 2000
Between 2000 and 2014, around 10,000 American children under 19 were hospitalized, and three died after taking methylphenidate or amphetamine, a new study reveals. (Source: the Mail online | Health)
Source: the Mail online | Health - May 21, 2018 Category: Consumer Health News Source Type: news

Unnecessary And Accidental Use Of ADHD Drugs Increases Over 60%, Study Suggests
(CNN) — Exposure to common medications used to treat attention deficit hyperactivity disorder has increased by more than 60% in US children and adolescents, according to a new study. The study, published Monday in the journal Pediatrics, looked at all calls to US poison control centers for unintentional or intentional exposure to ADHD medications between 2000 and 2014 among children and adolescents. The researchers found that the number of calls increased from 7,018 in 2000 to 11,486 in 2014 — a 64% increase. According to the study’s authors, “exposure” refers to the unnecessary ingestion, inh...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 21, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health ADHD Local TV Source Type: news

What Causes Flushing?
Discussion Flushing is usually thought of as a benign condition such as blushing, but can be quite irritating if it is frequent or persistent (i.e. menopausal hot flashes) or even pathologic (i.e. malignancy). “Flushing is a subjective and sensation of warmth that is accompanied by reddening of the skin anywhere on the body but favors the face, neck, and upper torso…. Flushing can be broadly divided into episodic or persistent. Episodic flashing is mediated by the release of endogenous vasoactive mediators or medications, while persistent flushing result in a fixed facial erythema with telangiectasias and cyan...
Source: PediatricEducation.org - April 30, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

April 2018 RxNorm Release Available for Download
The RxNorm April 2018 Release is now available for download. A new Qualitative Distinction (QD) modifier “BX Rating” is included to distinguish generic methylphenidate products not therapeutically equivalent to the brand-name drug Concerta. (Source: UMLS News)
Source: UMLS News - April 13, 2018 Category: Databases & Libraries Source Type: news

Experts Warn of Emerging ‘Stimulant Epidemic’
Abuse of stimulants like methamphetamine, cocaine and even prescription drugs like Adderall and Ritalin is surging across the country, fed by cheap, potent and plentiful supplies. (Source: WebMD Health)
Source: WebMD Health - April 3, 2018 Category: Consumer Health News Source Type: news